Literature DB >> 8558491

Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma.

W C Kisseberth1, E G MacEwen, S C Helfand, D M Vail, C L London, E Keller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8558491     DOI： 10.1111/j.1939-1676.1995.tb03304.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN： 0891-6640            Impact factor:   3.333


× No keyword cloud information.
  3 in total

Review 1.  Application of Biocompatible Drug Delivery Nanosystems for the Treatment of Naturally Occurring Cancer in Dogs.

Authors:  Nicola Ambrosio; Silvia Voci; Agnese Gagliardi; Ernesto Palma; Massimo Fresta; Donato Cosco
Journal:  J Funct Biomater       Date:  2022-08-07

2.  GS-9219/VDC-1101--a prodrug of the acyclic nucleotide PMEG has antitumor activity in spontaneous canine multiple myeloma.

Authors:  Douglas H Thamm; David M Vail; Ilene D Kurzman; Darius Babusis; Adrian S Ray; Noel Sousa-Powers; Daniel B Tumas
Journal:  BMC Vet Res       Date:  2014-01-25       Impact factor: 2.741

Review 3.  The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.

Authors:  Katarzyna Zabielska-Koczywąs; Roman Lechowski
Journal:  Molecules       Date:  2017-12-07       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.